Search alternatives:
significant co » significant _ (Expand Search), significant gap (Expand Search), significant factor (Expand Search)
point decrease » point increase (Expand Search)
co decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
Showing 21 - 40 results of 5,647 for search '(( significant co decrease ) OR ( significant ((point decrease) OR (mean decrease)) ))', query time: 0.54s Refine Results
  1. 21
    Study selection criteria.

    Study selection criteria. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 22
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 23
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 24
    PICOS criteria for the SLR.

    PICOS criteria for the SLR. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 25
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 26
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 27
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 28
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 29
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 30
    PRISMA flow chart.

    PRISMA flow chart. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 31
    Summary of clinical efficacy of relevant PTSD treatments.

    Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 32
    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.

    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 33
    Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index.

    Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. by Søren Egstrand (10906087)

    Published 2025
    “…All groups were compared by Kruskal Wallis test with <i>post hoc</i> test after Dunn with Bonferroni adjustment showing significant decreased Ki-67 labeling index of <i>Cina1</i> compared to <i>Cina2</i> (p = 0.006) and the untreated CKD groups (p = 0.0001 and p = 0.0002, respectively). …”
    Save to List
    Saved in:
  14. 34
    Mean standard errors across time points for the outcome of social stigma.

    Mean standard errors across time points for the outcome of social stigma. by Ana Beato (20489933)

    Published 2024
    Save to List
    Saved in:
  15. 35
    Means with standard errors across time points for the outcome of social distance.

    Means with standard errors across time points for the outcome of social distance. by Ana Beato (20489933)

    Published 2024
    Save to List
    Saved in:
  16. 36
    Means with standard errors across time points for the outcome of intergroup anxiety.

    Means with standard errors across time points for the outcome of intergroup anxiety. by Ana Beato (20489933)

    Published 2024
    Save to List
    Saved in:
  17. 37
    Table 1_Subjective spatial orientation discomfort is associated with decreased real-world spatial performance and lower cognitive function.docx

    Table 1_Subjective spatial orientation discomfort is associated with decreased real-world spatial performance and lower cognitive function.docx by Johannes Gerb (10287758)

    Published 2024
    Save to List
    Saved in:
  18. 38
    Raw data.

    Raw data. by Saeedeh Abbasi (9423189)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 39
    Data.

    Data. by Saeedeh Abbasi (9423189)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 40
    Example of a participant using the elevated surface (20 cm) during the intermittent footrest use (A) and the intermittent footrest use with arm flexion, hands crossed on the clavicles (B) conditions.

    Example of a participant using the elevated surface (20 cm) during the intermittent footrest use (A) and the intermittent footrest use with arm flexion, hands crossed on the clavic... by Saeedeh Abbasi (9423189)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: